Korro Bio, Inc.KRRONASDAQ
LOADING
|||

Analyst Sentiment

Analysts lean bullish — 80% recommend buying.

Consensus Rating
Buy
10 analysts·Moderate coverage
80%
Rating Distribution
Strong Buy
110%
Buy
770%
Hold
220%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 56% higher.

Bear Case
$10.00
-21%
Consensus
$19.67
+56%
Bull Case
$30.00
+138%
Price Range10 analysts
Low
Consensus
High
$10.00
$30.00
Current Target
Current Price
$12.59
Upside to Target
$7.09

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 29, 2026H.C. Wainwright
Korro Bio upgraded to Buy from Neutral at H.C. Wainwright
Target:$20.00
+71.1%from $11.69
Jan 29, 2026Chardan Capital
Korro Bio upgraded to Buy from Neutral at Chardan
Target:$15.00
+28.3%from $11.69
Jan 28, 2026Piper Sandler
Korro Bio upgraded to Overweight from Neutral at Piper Sandler
Target:$30.00
+156.6%from $11.69
Jan 28, 2026William Blair
William Blair Reiterates Market Perform Rating on Korro Bio Inc. (KRRO), 'early stages of its pipeline with clinical data unlikely until 2027'
Target:$10.00
-10.5%from $11.17
Jan 28, 2026Oppenheimer
Korro Bio upgraded to Outperform from Perform at Oppenheimer
Target:$22.00
+104.8%from $10.74
Jan 27, 2026Cantor Fitzgerald
Korro Bio upgraded to Overweight from Neutral at Cantor Fitzgerald
Target:$21.00
+95.5%from $10.74
Apr 16, 2025Chardan Capital
Korro Bio initiated with a Buy at Chardan
Target:$25.00
+85.7%from $13.46
Oct 21, 2024RBC Capital
Korro Bio Inc. (KRRO) PT Raised to $105 at RBC Capital
Target:$105.00
+36.5%from $76.94
May 15, 2024BMO Capital
BMO Capital Reiterates Outperform Rating on Korro Bio Inc. (KRRO)
Target:$120.00
+139.8%from $50.05
Mar 28, 2024H.C. Wainwright
Korro Bio Inc. (KRRO) PT Raised to $115 at H.C. Wainwright, 'KRRO-110 should be well-positioned'
Target:$115.00
+29.9%from $88.53
Mar 27, 2024RBC Capital
Korro Bio Inc. (KRRO) PT Raised to $90 at RBC Capital
Target:$90.00
+0.2%from $89.83